中国医药
中國醫藥
중국의약
CHINA MEDICINE
2011年
10期
1198-1200
,共3页
吴小飞%王华雨%杨爱平%周宝勤%汤伟
吳小飛%王華雨%楊愛平%週寶勤%湯偉
오소비%왕화우%양애평%주보근%탕위
慢性乙型肝炎%乙型肝炎病毒%调节性T细胞
慢性乙型肝炎%乙型肝炎病毒%調節性T細胞
만성을형간염%을형간염병독%조절성T세포
Chronic hepatitis B%Hepatitis B virus%Regulatory T-lymphocytes
目的 探讨慢性乙型肝炎患者外周血CD4+CD25+调节性T细胞(CD4+ CD25+ Treg)检测的临床意义。方法 慢性HBV感染者48例(慢性HBV携带者10例为慢性HBV携带者组、慢性乙型肝炎18例慢性乙型肝炎组和乙肝肝硬化为乙肝肝硬化组20例),以流式细胞仪检测血CD4+CD25+Treg细胞频率,实时荧光定量聚合酶链反应检测血HBV DNA载量。结果 血CD4+CD25+Treg细胞百分率:慢性HBV携带者组为(6.72±2.60)%、慢性乙型肝炎组为(8.56±3.12)%、乙肝肝硬化组为(11.59±4.34)%,组间差异有统计学意义(均P<0.05)。血HBV DNA载量:慢性HBV携带者组为1.7 ×106拷贝/ml、慢性乙型肝炎组为4.3 ×105拷贝/ml、乙肝肝硬化组为6.8 ×104拷贝/ml,组间差异有统计学意义(P<0.01);慢性肝病患者血CD4+CD25+调节性T细胞百分率与HBV DNA滴度正相关。结论 慢性肝病患者血Treg细胞频率与HBVDNA滴度正相关,提示Treg细胞在慢性乙型肝炎致病机制中起重要作用。
目的 探討慢性乙型肝炎患者外週血CD4+CD25+調節性T細胞(CD4+ CD25+ Treg)檢測的臨床意義。方法 慢性HBV感染者48例(慢性HBV攜帶者10例為慢性HBV攜帶者組、慢性乙型肝炎18例慢性乙型肝炎組和乙肝肝硬化為乙肝肝硬化組20例),以流式細胞儀檢測血CD4+CD25+Treg細胞頻率,實時熒光定量聚閤酶鏈反應檢測血HBV DNA載量。結果 血CD4+CD25+Treg細胞百分率:慢性HBV攜帶者組為(6.72±2.60)%、慢性乙型肝炎組為(8.56±3.12)%、乙肝肝硬化組為(11.59±4.34)%,組間差異有統計學意義(均P<0.05)。血HBV DNA載量:慢性HBV攜帶者組為1.7 ×106拷貝/ml、慢性乙型肝炎組為4.3 ×105拷貝/ml、乙肝肝硬化組為6.8 ×104拷貝/ml,組間差異有統計學意義(P<0.01);慢性肝病患者血CD4+CD25+調節性T細胞百分率與HBV DNA滴度正相關。結論 慢性肝病患者血Treg細胞頻率與HBVDNA滴度正相關,提示Treg細胞在慢性乙型肝炎緻病機製中起重要作用。
목적 탐토만성을형간염환자외주혈CD4+CD25+조절성T세포(CD4+ CD25+ Treg)검측적림상의의。방법 만성HBV감염자48례(만성HBV휴대자10례위만성HBV휴대자조、만성을형간염18례만성을형간염조화을간간경화위을간간경화조20례),이류식세포의검측혈CD4+CD25+Treg세포빈솔,실시형광정량취합매련반응검측혈HBV DNA재량。결과 혈CD4+CD25+Treg세포백분솔:만성HBV휴대자조위(6.72±2.60)%、만성을형간염조위(8.56±3.12)%、을간간경화조위(11.59±4.34)%,조간차이유통계학의의(균P<0.05)。혈HBV DNA재량:만성HBV휴대자조위1.7 ×106고패/ml、만성을형간염조위4.3 ×105고패/ml、을간간경화조위6.8 ×104고패/ml,조간차이유통계학의의(P<0.01);만성간병환자혈CD4+CD25+조절성T세포백분솔여HBV DNA적도정상관。결론 만성간병환자혈Treg세포빈솔여HBVDNA적도정상관,제시Treg세포재만성을형간염치병궤제중기중요작용。
Objective To investigate the clinical value of circulating T regulatory cell (Treg) in patients with chronic hepatitis B (CHB). Methods The circulating Treg frequency and the levels of HBV replication in 48 patients with CHB, including 10 HBV carriers, 18 CHB, and 20 liver cirrhosis ( LC), were analyzed by fluorescence-activated cell sorting (FACS) and by real-time Polymerase Chain Reaction ( PCR), respectively. Results Tregs frequency was (11.59 ±4.34)% (P <0.05) in LC and significantly higher than that in CHB (8.56 ±3.12) % or in HBV carries (6.72 ± 2.60)%. HBV DNA copies was 1.7 × 106 copies/ml (P < 0.01 ) in HBV carriers and significantly higher than that in CHB (4.3 × 105 ) copies/ml or in LC (6.8 × 104 ) copies/ml. Significant relationship was found between Treg frequency and HBV DNA copies. Conclusions Circulating Treg would play an important role in CHB infection with correlated closely with the viral replication.